March 2011

AJR: Cardiac CT triage scores a triple ()
Check out the ACC.11 highlights ()
AIM: Older patients still underrepresented in HF trials ()
ACC/AHA guidelines outline proper management for non-STEMI patients ()
JACC: Benefits of statins outweigh slight increase of new-onset diabetes ()
Health Reform in the Era of Uncertainty: Implications for the Cardiovascular Practice ()
AIM: Do conflicts of interests impact clinical practice guidelines? ()
Medrad taps Darby as VP of interventional unit ()
N.Y., Mass. providers exchange cardio images with lifeIMAGE ()
Toshiba offers new features for Infinix-i cardiovascular system ()
OrbusNeich sues its principal investigator ()
Stroke: MI incidence doubles after TIA ()
Planning with an Uncertain Financial Future ()
Will ECG Become Standard Screening Tool for Young Athletes? ()
Q&A: Why was the TRIGGER-PCI pulled so soon? ()
Study: Resuscitated survivors have good quality of life ()
Study: Rapid response lowers in-hospital arrests ()
USA Volleyball staff get CPR, AED training ()
Circ: Brief video training boosts hands-only CPR attempts ()
Study: ECG screening helps prevent SCD during sports ()
JACR: Top 5 tips for ending self-referral ()
Kings of CABG: Surgeons Adapt Methods for Patients ()
First Word: Politics & Cardiology Practice Collide ()
Next-Generation Stent Technologies: Shedding the Metal ()
PinnacleHealth Heart Recovery Program Aims to Stabilize Unstable Shock Patients ()
Risk Stratification for CV Disease Gets Personal ()
Off-hour Cath Lab Scheduling ()
Overcoming Barriers to Routine Use of IVUS, FFR & OCT ()
Inside the Transition to Flow-Based Patient Care ()
Monitoring Patients from the OR to Rehab ()
Monitoring Patients from the OR to Rehab ()
Managing Chronic Angina: What Do We Know? ()
AoS: Prolonging surgery post-MI can reduce death ()
The ACC Corner | Closing the Gender Gap: Women & CV Disease ()
Meaningful Use Stage 2: Targeting Specialties ()
Merck gives rights to anticoagulant back to Portola ()
News & Views ()
Back Page | Pradaxa: First Five Months of a New Era ()
NEJM: Actos prevents diabetes in 72% of pre-diabetics ()
JACC: Radial access causes more rad exposure than femoral ()
Report: AF burden high, resources scarce ()
JCL: LDL-P levels may better predict CVD risk than cholesterol ()
JAMA Feature: More sensitive troponin test IDs more at risk of MI ()
AHJ: Primary PCI should be first-line reperfusion strategy, if accessible ()
Takeda, Amylin halt obesity drug trial ()
Circ statement: More aggressive treatment strategies for extreme VTE needed ()
CCI: How to implement quality improvement in the cath lab ()
BMJ: More bad news for Avandia & its link with cardiac events ()
CMAJ: Combining ACE inhibitors + ARBs in elderly increases death, kidney failure ()
JACC: LVADs promising for end-stage HF patients ()
Circ: Gender bias found with FDA-approved devices ()
Corindus launches PRECISE robotics PCI trial ()
JACC: Left main in-stent restenosis MACE equal to CABG ()
JACS: Outcomes not better at higher volume surgical hospitals ()
Covidien's stroke device moves SWIFTly to FDA queue for approval ()
Global imaging market topped $21B in 2010 ()
Medicare physician payment cuts resurface ()
AHJ: Renal revascularization + medical therapy decreases hypertension meds ()
JAMA: Trials need to prove biomarker link of CV events, chronic kidney disease ()
Time to think about how C-PACS/CVIS fit into hospital-wide EHR ()
JACC: Initial restenosis pattern is important predictor of reintervention ()
GSK, Tolerx diabetes drug fails to meet phase III primary endpoint ()
Lancet: BMI, waist measurements have similar CV risk prediction ()
NEJM: ACTIVE I published; irbesartan doesn't reduce CV events in AF patients ()
FDA slaps Cordis with warning over stent manufacturing ()
JAMA: Conflicts of interests under-reported in meta-analyses ()
Medtronic pays $750K and Bovie exits RF device market in settlement ()
U.K. hospital to install Agfa RIS/PACS, CR & cardio ()
NEJM: Dose optimization of diuretics for HF does not alter outcomes ()
CRT: Lack of funding is stifling U.S. medical innovation ()
ACO success in northern Calif. spreads to San Francisco ()
CRT: Erectile dysfunction may present stenting option for CAD prevention ()
Feature: New HF risk marker may gauge autonomic nervous system ()
Study: AF stroke survivors may have greater chance of developing dementia ()
Feature: Genetic study on warfarin responsiveness begins ()
Study: ICDs may be beneficial early post-MI ()
CCI feature: Carotid stenting more cost-effective; will it replace CEA? ()
AJC: Blood test could trump clinical judgment in HF discharge management ()
CRT: Xience proves safe, effective in small vessels too ()
JACC: Only 27% of MI patients revascularized by CABG take Plavix ()
CRT: Patient characteristics better predict outcomes than treatment choice for CTOs ()
AIM: Should we lower the bar for CRT in heart failure? ()
Study: High glucose levels linked with inpatient death in nondiabetics ()